Cargando…
Drug–Drug Interactions in Patients with COVID-19 in Nursing Homes
Autores principales: | Correard, Florian, Couderc, Anne-Laure, Arcani, Robin, Weiland, Joris, Courcier, Anais, Berard, Charlotte, Miola, Charlène, Berbis, Julie, Villani, Patrick, Daumas, Aurélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009758/ https://www.ncbi.nlm.nih.gov/pubmed/33788163 http://dx.doi.org/10.1007/s40266-021-00854-6 |
Ejemplares similares
-
Factors Associated With COVID-19 Hospitalizations and Deaths in French Nursing Homes
por: Couderc, Anne-Laure, et al.
Publicado: (2021) -
Centenarians in nursing homes during the COVID-19 pandemic
por: Couderc, Anne-Laure, et al.
Publicado: (2021) -
Tocilizumab versus anakinra in COVID-19: results from propensity score matching
por: Arcani, Robin, et al.
Publicado: (2023) -
Acceptability of a Novel Telemedication Review for Older Adults in Nursing Homes in France: A Qualitative Study
por: Costa, Marie, et al.
Publicado: (2021) -
Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial
por: Correard, F., et al.
Publicado: (2020)